{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:58:11Z","timestamp":1790888291172,"version":"4.1.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Pathogenesis and Therapy"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.cpt.2026.05.002","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T23:21:36Z","timestamp":1779751296000},"page":"335-339","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Moving cardio-oncology upstream: Integrating cardiovascular prevention into routine cancer care"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9114-9633","authenticated-orcid":false,"given":"Meiyan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpt.2026.05.002_bib1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4103\/hm.HM-D-24-00148","article-title":"Bridging cancer and cardiovascular health: a comprehensive review of cardiotoxicity in modern oncology","volume":"9","author":"Rajpoot","year":"2025","journal-title":"Heart Mind"},{"key":"10.1016\/j.cpt.2026.05.002_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semcancer.2026.01.004","article-title":"Cancer therapy-related cardiovascular toxicity: current progress and future perspectives","volume":"120","author":"Shang","year":"2026","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.cpt.2026.05.002_bib3","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12933-021-01346-y","article-title":"The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin","volume":"20","author":"Quagliariello","year":"2021","journal-title":"Cardiovasc Diabetol"},{"issue":"5","key":"10.1016\/j.cpt.2026.05.002_bib4","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.cpt.2025.12.003","article-title":"Multidimensional perspectives on cancer therapy-induced cardiotoxicity: characteristics, mechanisms, biomarkers, psychological stress effects, and treatment progress","volume":"4","author":"Chen","year":"2025","journal-title":"Cancer Pathog Ther"},{"key":"10.1016\/j.cpt.2026.05.002_bib5","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.3390\/cancers17193225","article-title":"Cancer-induced cardiac dysfunction: mechanisms, diagnostics, and emerging therapeutics in the era of onco-cardiology","volume":"17","author":"Saha","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.cpt.2026.05.002_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.742193","article-title":"Divergent cardiac effects of angiotensin II and isoproterenol following Juvenile exposure to doxorubicin","volume":"9","author":"Agostinucci","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.cpt.2026.05.002_bib7","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1007\/s00330-012-2726-5","article-title":"Reliable categorisation of visual scoring of coronary artery calcification on low-dose CT for lung cancer screening: validation with the standard Agatston score","volume":"23","author":"Huang","year":"2013","journal-title":"Eur Radiol"},{"key":"10.1016\/j.cpt.2026.05.002_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2021.106540","article-title":"Qualitative coronary artery calcification scores and risk of all cause, COPD and pneumonia hospital admission in a large CT lung cancer screening cohort","volume":"186","author":"Gazourian","year":"2021","journal-title":"Respir Med"},{"key":"10.1016\/j.cpt.2026.05.002_bib9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s11748-021-01754-7","article-title":"Primary and secondary cardiac tumors: clinical presentation, diagnosis, surgical treatment, and results","volume":"70","author":"Campisi","year":"2022","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cpt.2026.05.002_bib10","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.cpt.2025.11.001","article-title":"Right atrial intimal sarcoma with liver metastasis: a case report and literature review","volume":"4","author":"You","year":"2026","journal-title":"Cancer Pathog Ther"},{"key":"10.1016\/j.cpt.2026.05.002_bib11","doi-asserted-by":"crossref","first-page":"7535","DOI":"10.3390\/ijms24087535","article-title":"Intimal sarcoma with MDM2\/CDK4 amplification and p16 overexpression: a review of histological features in primary tumor and xenograft, with immunophenotype and molecular profiling","volume":"24","author":"Giner","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cpt.2026.05.002_bib12","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00428-017-2135-x","article-title":"Cardiac intimal sarcoma with PDGFR\u03b2 mutation and co-amplification of PDGFR\u03b1 and MDM2: an autopsy case analyzed by whole-exome sequencing","volume":"471","author":"Ito","year":"2017","journal-title":"Virchows Arch"},{"key":"10.1016\/j.cpt.2026.05.002_bib13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/hm.HM-D-24-00096","article-title":"The forgotten connection: mental health and cardiovascular disease","volume":"9","author":"Sanchis-Gomar","year":"2025","journal-title":"Heart Mind"},{"key":"10.1016\/j.cpt.2026.05.002_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.apnu.2025.152024","article-title":"Psycho-oncology: bridging mental health and cancer care in modern medicine","volume":"60","author":"Upadhyay","year":"2026","journal-title":"Arch Psychiatr Nurs"},{"key":"10.1016\/j.cpt.2026.05.002_bib15","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","volume":"43","author":"Lyon","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpt.2026.05.002_bib16","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/CRD.0000000000000252","article-title":"The preventive role of angiotensin converting enzyme Inhibitors\/Angiotensin-II receptor blockers and \u03b2-Adrenergic blockers in Anthracycline- and trastuzumab-induced cardiotoxicity","volume":"27","author":"Blanter","year":"2019","journal-title":"Cardiol Rev"},{"key":"10.1016\/j.cpt.2026.05.002_bib17","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jchf.2022.03.006","article-title":"Sodium-glucose co-transporter-2 inhibitors and cardiac outcomes among patients treated with anthracyclines","volume":"10","author":"Gongora","year":"2022","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cpt.2026.05.002_bib18","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.033700","article-title":"Low-dose colchicine ameliorates doxorubicin cardiotoxicity via promoting autolysosome degradation","volume":"13","author":"Peng","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cpt.2026.05.002_bib19","doi-asserted-by":"crossref","first-page":"647","DOI":"10.4314\/ahs.v21i2.21","article-title":"Rational and design of SATRACD study: detecting subclinical anthracycline therapy related cardiac dysfunction in low income country","volume":"21","author":"Zhang","year":"2021","journal-title":"Afr Health Sci"}],"container-title":["Cancer Pathogenesis and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949713226000261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949713226000261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:26:09Z","timestamp":1790886369000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949713226000261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2949713226000261"],"URL":"https:\/\/doi.org\/10.1016\/j.cpt.2026.05.002","relation":{},"ISSN":["2949-7132"],"issn-type":[{"value":"2949-7132","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Moving cardio-oncology upstream: Integrating cardiovascular prevention into routine cancer care","name":"articletitle","label":"Article Title"},{"value":"Cancer Pathogenesis and Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpt.2026.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V. on behalf of Chinese Medical Association (CMA).","name":"copyright","label":"Copyright"}]}}